ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

0A4Y Aim Immunotech Inc

0,00
0,00 (0,00%)
Nom Action Symbole Action Marché Type
Aim Immunotech Inc 0A4Y London Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% -
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
10/4/202414:21UKREGAIM ImmunoTech Announces Positive Top-Line, Protocol-Planned..
02/4/202413:30UKREGAIM ImmunoTech Reports Fourth Quarter and Full Year 2023..
26/3/202414:05UKREGAIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023..
25/3/202414:05UKREGAIM ImmunoTech Announces Publication of Positive Findings..
07/3/202414:45UKREGAIM ImmunoTech Announces Launch of CEO Corner Platform
29/2/202414:45UKREGAIM ImmunoTech Outlines Recent Progress Across Clinical..
14/2/202414:55UKREGAIM ImmunoTech Announces First Subject Dosed in the..
24/1/202415:10GLOBEAIM ImmunoTech Receives Erasmus Medical Center Ethics Board..
22/1/202414:55GLOBEAIM ImmunoTech Announces that the First Subject is Enrolled..
10/1/202414:45GLOBEAIM ImmunoTech Announces Open Enrollment for Phase 1b/2..
27/11/202315:05GLOBEAIM ImmunoTech Bolsters Intellectual Property Estate for..
15/11/202313:30GLOBEAIM ImmunoTech Reports Third Quarter 2023 Financial Results..
09/11/202314:05GLOBEAIM ImmunoTech to Discuss Third Quarter 2023 Financial..
17/10/202314:45GLOBEAIM ImmunoTech Engages Business Development Firm, Azenova,..
11/9/202319:00GLOBEAIM ImmunoTech Announces Report of Complete Topline Data..
15/8/202312:45GLOBEAIM ImmunoTech Reports Second Quarter Financial Results and..
09/8/202315:05GLOBEAIM ImmunoTech to Discuss Second Quarter 2023 Financial..
08/8/202314:05GLOBEAIM ImmunoTech Announces Completion of Enrollment in Phase 2..
19/7/202301:30GLOBEAIM ImmunoTech Issues Notice that an Unaffiliated Third..
10/7/202314:05GLOBEAIM ImmunoTech Enrolls and Doses First Subject in Phase 2..
27/6/202317:16GLOBEAIM ImmunoTech Announces Publication of Positive Findings..
27/6/202314:45GLOBEAIM ImmunoTech Announces Authorizations from Competent..

Dernières Valeurs Consultées

Delayed Upgrade Clock